WHO/Ramy Srour
© Credits

Cancer

    Overview

    Cancer is the uncontrolled growth and spread of cells that arises from a change in one single cell. The change may be started by external agents and/or inherited genetic factors and can affect almost any part of the body. The transformation from a normal cell into a tumour cell is a multistage process where growths often invade surrounding tissue and can metastasize to distant sites. These changes result from the interaction between a person’s genetic factors and any of 3 categories of external agents:

    • physical carcinogens, such as ultraviolet and ionizing radiation or asbestos;
    • chemical carcinogens, such as vinyl chloride, or betnapthylamine (both rated by the International Agency for Research into Cancer as carcinogenic), components of tobacco smoke, aflatoxin (a food contaminant) and arsenic (a drinking-water contaminant); and
    • biological carcinogens, such as infections from certain viruses, bacteria or parasites.

    Most chemicals to which people are exposed in everyday life have not been tested for their long-term impact on human health.

    Many cancers can be prevented by avoiding exposure to common risk factors, such as tobacco smoke. In addition, a significant proportion of cancers can be cured, by surgery, radiotherapy or chemotherapy, especially if they are detected early.

    Impact

    Cancer is the most important cause of death and morbidity in Europe after cardiovascular diseases. With more than 3.7 million new cases and 1.9 million deaths each year, cancer represents the second most important cause of death and morbidity in Europe.

    WHO response

    WHO/Europe assists countries to develop national programmes for cancer control. The International Agency for Research on Cancer (IARC) is the WHO body that specializes in this field. It coordinates and conducts research on causes and develops scientific strategies for cancer prevention and control.

    20%

    The percentage of deaths caused by cancer in the European Region

    Our work

    All →
    Reducing childhood cancer inequalities

    Reducing childhood cancer inequalities

    WHO
    © Credits

    Overview

    There has been rapid progress in childhood cancer survival rates over the past decades in the WHO European Region, but improvements have not been experienced equally across countries. While it is possible to cure more than 80% of childhood cancers, the annual death rate for children diagnosed with cancer ranges from 9% to 57% across countries. Overall, 20% of children diagnosed with cancer in the Region still die from cancer. WHO/Europe is working with partners to better understand inequalities in childhood cancer incidence and care across and within countries. In 2021,

    WHO/Europe published a report that set out for the first time the evidence on childhood cancer inequalities in the 53 countries of the Region. It shows that childhood cancer inequalities are experienced along the whole cancer care continuum, affecting diagnosis, access to care, care quality, follow-up care, mortality and survivorship experiences.

    It is believed that most if not all of the variations in childhood cancer incidence rates in some sub-regions are due to underdiagnosis and underreporting. This underscores the importance of investment in data collection and analysis to understand the situation, measure inequalities, and inform decision-making for investment. 

    This work is part of the WHO Global Initiative for Childhood Cancer, generously supported by St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America, which aims to increase the survival rate of children with cancer globally to at least 60% by 2030 while reducing suffering and improving quality of life. The mechanism for this work is the CureAll framework designed for policy-makers and managers to assess and strengthen childhood cancer services. 

    Reducing childhood cancer inequalities is also part of WHO/Europe’s United Action Against Cancer movement, to improve outcomes for children with cancer and to ultimately eliminate cancer as a life-threatening disease.

    Multimedia

    All →

    Infographics

    All →

    Publications

    All →
    Prevention and control of noncommunicable diseases in Georgia: case for investment

    Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory disease pose a major threat to health and economic...

    Small Countries Initiative impact report 2021–2024: four years of progress

    The Small Countries Initiative (SCI), established in 2013, serves as a collaborative platform for 12 Member States in the WHO European Region, each with...

    Documents

    All →

    The clock is ticking. With just five years left to achieve 2030 Sustainable Development Goal (SDG) 3.4 of reducing premature deaths from noncommunicable...

    In too many countries, the majority of women are diagnosed too late, multidisciplinary treatment and follow-up care are suboptimal, and supportive and...

    Related WHO collaborating centres

    WHO collaborating centres are institutions that form an international collaborative network carrying out activities to support WHO’s programmes at all levels. They provide an opportunity for WHO to utilize their inherent expertise for the benefit of all Member States.

    View the list of related collaborating centres